Dr. Hayden is a Killam Professor at the University of British Columbia and Senior Scientist at the Centre for Molecular Medicine and Therapeutics.
Author of over 900 peer-reviewed publications, Dr. Hayden’s research focuses on genetic diseases, including gene therapy, Huntington disease, predictive and personalized medicine and drug development. Dr. Hayden identified the first mutations underlying lipoprotein lipase (LPL) deficiency and developed gene therapy approaches to treat this condition, the first approved gene therapy (Glybera) in the western world.
He is the most cited author in the world on ABCA1 and Huntington disease.
Dr. Hayden is the recipient of numerous prestigious honours and awards. He was inducted into the Canadian Medical Hall of Fame in 2017; awarded the Order of Canada (2011), and the Order of British Columbia (2010). Dr. Hayden is committed to empowering others. In addition to mentoring over 100 graduate students and postdocs, he is also a TED mentor.